Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

Arthritis and Rheumatism

Volumn 40, Issue 11, 1997, Pages 2007-2015

  Agnello, Vincent ^a,b   Ábel, György ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b Center for Health Quality Outcomes and Economic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE SEVERITY; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INFECTION; VASCULITIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS PATHOGENESIS;

BIOPSY; CRYOGLOBULINEMIA; CRYOGLOBULINS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTES; PURPURA; RECEPTORS, LDL; RNA, VIRAL; SKIN; UP-REGULATION;

EID: 0030867085     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401113     Document Type: Article

References (24)

1. Meltzer M, Franklin EC: Cryoglobulinemia: a study of twentynine patients. 1. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 40:828-836, 1966
2. Abel G, Zhang Q-X, Agnello V: Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36:1341-1349, 1993
3. Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S: Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 23:399-405, 1993
4. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II crvoglobulinemia. N Engl J Med 327:1490-1495, 1992
5. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L: Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388, 1991
6. Lau JYN, Krawczynski K, Negro F, Gonzalez-Peralta RP: In-situ detection of hepatitis C virus: a critical appraisal. J Hepatol 20:43-51, 1996
7. Durand JM, Lefevre P, Harle JR, Boucrat J, Vitviski L, Soubeyrand J: Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection (letter). Lancet 337:499-500, 1991
8. Agnello V, Ábel G, Knight GB, Muchmore E: Detection of widespread hepatocyte infection in chronic hepatitis C. Submitted for publication
9. Kays A, Innerarity T, Pitas R, Mahley R: Protocol 15. In, Lipoprotein Analysis: A Practical Approach. Edited by C Sonnverse, E Skinner. New York, Oxford University Press, 1992
10. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N: Cryoglobulinemia - a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40:837-856, 1966
11. Madi N, Steiger G, Estreicher J, Schifferli JA: Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II. J Immunol 147:495-502, 1991
12. Sansonno D, Cornacchiulo V, Lacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21: 305-312, 1995
13. Boom BW, Mommaas AM, Vermeer BJ: Presence and interpretation of vascular immune deposits in human skin: the value of direct immunofluorescence. J Dermatol Sci 3:26-34, 1992
14. Cochrane CG, Weigle WO, Dixon FJ: The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J Exp Med 110:481-494, 1959
15. Cream JJ, Bryceson ADM, Ryder G: Disappearance of immunoglobulins and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Br J Dermatol 84:106-109, 1971
16. Gower RG, Sams WM Jr, Thorne EG, Kohler PF, Claman HN: Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol 69:477-484, 1977
17. Zax RH, Hodge SJ, Callen JP: Cutaneous leukocytoclastic vasculitis: serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol 126:69-72, 1990
18. Shindo M, Di Bisceglie AM, Akatsuka T, Fong TL, Scaglione L, Donets M, Hoofnagle JH, Feinstone SM: The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. Proc Natl Acad Sci U S A 91:8719-8723, 1994
19. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR: Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202:606-614, 1994
20. Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 93:38-44, 1992
21. Lee WY, Lockniskar MF, Fischer SM: Interleukin-lα mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J 8:1081-1087, 1994
22. Agnello V, Ábel G, Zhang QX, Elfahal M, Knight GB: Low density lipoprotein receptor (LDLR) mediated endocytosis of hepatitis C virus (HCV): a potential mechanism for infection of hepatocytes, IX Triennial International Symposium on Viral Hepatitis and Liver Disease. Rome, Italy, April 1996
23. Ponec M, te Pas MF, Havekes L, Boonstra J, Mommaas AM, Vermeer BJ: LDL receptors in keratinocytes. J Invest Dermatol 98 (suppl 6):50S-56S, 1992
24. Casato M, Lagan AB, Antonelli G, Dianzani F, Bonomo L: Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 78:3142-3147, 1991